Chu Lin

783 total citations
55 papers, 516 citations indexed

About

Chu Lin is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Chu Lin has authored 55 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Surgery and 13 papers in Molecular Biology. Recurrent topics in Chu Lin's work include Diabetes Treatment and Management (30 papers), Diabetes Management and Research (15 papers) and Metabolism, Diabetes, and Cancer (10 papers). Chu Lin is often cited by papers focused on Diabetes Treatment and Management (30 papers), Diabetes Management and Research (15 papers) and Metabolism, Diabetes, and Cancer (10 papers). Chu Lin collaborates with scholars based in China, United Kingdom and United States. Chu Lin's co-authors include Xiaoling Cai, Fang Lv, Jun Zhang, Linong Ji, Wenjia Yang, Xingyun Zhu, Lin Nie, Jun Zhang, Linong Ji and Jun Zhang and has published in prestigious journals such as Frontiers in Immunology, European Journal of Pharmacology and Obesity Reviews.

In The Last Decade

Chu Lin

48 papers receiving 512 citations

Peers

Chu Lin
Jiandong Zhang China
Ji Hu China
M. Elizabeth Moss United States
Tadashi Arao Japan
Giuseppe Scavone Italy
Zilin Sun China
Melanie Schwenk Germany
Zsuzsanna Valkusz Hungary
Keiichi Torimoto Japan
Shali Zhang United States
Jiandong Zhang China
Chu Lin
Citations per year, relative to Chu Lin Chu Lin (= 1×) peers Jiandong Zhang

Countries citing papers authored by Chu Lin

Since Specialization
Citations

This map shows the geographic impact of Chu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chu Lin more than expected).

Fields of papers citing papers by Chu Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chu Lin. The network helps show where Chu Lin may publish in the future.

Co-authorship network of co-authors of Chu Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Chu Lin. A scholar is included among the top collaborators of Chu Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chu Lin. Chu Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Wei, Xiaoling Cai, Yu Zhu, et al.. (2025). Metabolic syndrome in type 1 diabetes: higher time above range and glycemic variability revealed by continuous glucose monitoring (CGM). Diabetology & Metabolic Syndrome. 17(1). 49–49. 2 indexed citations
3.
4.
5.
6.
Lv, Fang, et al.. (2024). Effects of Semaglutide and Tirzepatide on Bone Metabolism in Type 2 Diabetic Mice. Pharmaceuticals. 17(12). 1655–1655. 9 indexed citations
7.
Liu, Wei, Shenda Hong, Yu Zhu, et al.. (2024). Development and external validation of an algorithm for self‐identification of risk for microvascular complications in patients with type 1 diabetes. Diabetes Obesity and Metabolism. 27(2). 740–749. 1 indexed citations
8.
9.
Lin, Chu, Xiaoling Cai, Fang Lv, et al.. (2024). The opportunities and challenges of the disease-modifying immunotherapy for type 1 diabetes: A systematic review and meta-analysis. Pharmacological Research. 203. 107157–107157. 7 indexed citations
10.
Zhang, Rui, Xiaoling Cai, Chu Lin, et al.. (2023). Primary aldosteronism and obstructive sleep apnea: A meta-analysis of prevalence and metabolic characteristics. Sleep Medicine. 114. 8–14. 4 indexed citations
11.
Lin, Chu, Xiaoling Cai, Xingyun Zhu, et al.. (2023). Baseline eGFR, albuminuria and renal outcomes in patients with SGLT2 inhibitor treatment: an updated meta-analysis. Acta Diabetologica. 60(3). 435–445. 9 indexed citations
12.
Lin, Chu, Xingyun Zhu, Xiaoling Cai, et al.. (2023). Population attributable fractions of modifiable risk factors for microvascular complications of type 2 diabetes in China: An analysis using national cross‐sectional data. Diabetes Obesity and Metabolism. 25(S1). 5–12. 2 indexed citations
13.
Yang, Wenjia, et al.. (2023). Evaluation of efficacy and safety of glucokinase activators—a systematic review and meta-analysis. Frontiers in Endocrinology. 14. 1175198–1175198. 7 indexed citations
14.
15.
Zhang, Rui, Xiaoling Cai, Chu Lin, et al.. (2022). The association between metabolic parameters and evening chronotype and social jetlag in non-shift workers: A meta-analysis. Frontiers in Endocrinology. 13. 1008820–1008820. 24 indexed citations
16.
Cai, Xiaoling, et al.. (2021). Non-Insulin Antidiabetes Treatment in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Diabetes & Metabolism Journal. 45(3). 312–325. 9 indexed citations
17.
Zhu, Xingyun, Lina Zhao, Jing Chen, et al.. (2021). The Effect of Physical Activity on Glycemic Variability in Patients With Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Frontiers in Endocrinology. 12. 767152–767152. 16 indexed citations
18.
19.
Lin, Chu, Xiaoling Cai, Wenjia Yang, et al.. (2020). Glycemic control and the incidence of neoplasm in patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Endocrine. 70(2). 232–242. 13 indexed citations
20.
Lin, Chu & Jun Zhang. (2019). Chimeric antigen receptor engineered innate immune cells in cancer immunotherapy. Science China Life Sciences. 62(5). 633–639. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiandong Zhang Breakdown of academic impact, for papers by Ji Hu Breakdown of academic impact, for papers by M. Elizabeth Moss Breakdown of academic impact, for papers by Tadashi Arao Breakdown of academic impact, for papers by Giuseppe Scavone Breakdown of academic impact, for papers by Zilin Sun Breakdown of academic impact, for papers by Melanie Schwenk Breakdown of academic impact, for papers by Zsuzsanna Valkusz Breakdown of academic impact, for papers by Keiichi Torimoto Breakdown of academic impact, for papers by Shali Zhang
Rankless by CCL
2026